2016 - Page 2

The PharmaSafe group has participated in a comparative study between Serbia and Norway.

The recently published study "Effect of prenatal selective serotonin reuptake inhibitor (SSRI) exposure on birthweight and gestational age: a sibling-controlled cohort study" has now been featured on forskning.no.

Dr. Michael Twigg from the University of East Anglia, who stayed at the PharmaSafe group in September 2015 has just published a new article in the International Journal of Clinical Pharmacy

According to the new Norwegian popular science magazine Aftenposten Vitenskap (Science), PharmaSafe group leader Hedvig Nordeng is one of 25 Norwegian scientists you should have heard of.

The PharmaSafe group has published a new article in "The International Journal of Epidemiology".

PharmaSafe PhD student Kristine Heitmann will defend her PhD thesis at the University of Bergen on 25 May. The title of her thesis is "Treatment of nausea and vomiting during pregnancy- with special focus on attitudes to and use of pharmacological treatment".

Om NFIF gjesteforelesningen med Dr. Ross T. Tsuyuki: Hvilke roller kanadiske farmasøyter har i dag og hvordan de har jobbet for å utvikle nye offentlige pasienttjenester i apotek.

A new study by Master's students of the PharmaSafe group under the direction of Prof. Hedvig M.E. Nordeng was just published in the European Journal of Clinical Pharmacology. This article was now featured in Dagens Medisin.

We are very happy to welcome Erika Olsson og Ali Mohamad Ali to our group.

The PharmaSafe group has published another article and a book chapter in March. In addition, the scientific article was featured on titan.uio.no and forskning.no.

The PharmaSafe group and the PharmaSafe Research Initiative are proud to present a guest lecture by Dr. Jacqueline Cohen, Postdoc at Harvard T.H. Chan School of Public Health.

PharmaSafe PhD student Kristine Heitmann just published an article in the European Journal of Clinical Pharmacology on nausea during pregnancy. This article was now featured on forskning.no

The PharmaSafe group has been granted 675,000 NOK per year for three years from the Norwegian Women's Public Health Association to finance one PhD student.

We are very happy to welcome Hilde Ariansen to our group.

Another two studies by the PharmaSafe group were published this February.

PharmaSafe gruppen organiserer en seminar med tittelen "Pharmacoepidemiology: an important discipline for pharmacy students".

As part of The Forum for causal interference, PharmaSafe's Mollie Wood will be giving a lecture with the title: "Exposure misclassification and propensity score methods: a simulation study"

The PharmaSafe group has experienced a good start into the year 2016.